@KYli bro see how they spin a good story to bad.
The actual story
“This is a very successful completion of contract that we have with China and this Sinovac vaccine,” said Sec. Carlito Galvez Jr., vaccine czar and chief implementer of the National Task Force (NTF) Against COVID-19.
“The Filipino people will always be grateful to the Chinese government and Sinovac for facilitating the continuous, and steady, and timely delivery of the life-saving vaccines,” he added.
The Sinovac shots were the first COVID-19 vaccines that arrived in the country during the onset of the pandemic last year.
The arrival of 600,000 doses of vaccine donation on February 28, 2020 paved the way for the rollout of the national vaccination program in March.
But Galvez pushed through with the use of Sinovac amid heavy criticisms from several individuals and organizations if only to offer at least some form of protection to the most vulnerable sectors such as the healthcare workers, senior citizens, and persons with comorbidities.
And now the Spin
However, the vaccination program had a bumpy start as vaccine hesitancy was evident among the public due to Sinovac’s lower efficacy compared to other Western-made brands.
While Sinovac-CoronaVac offered around 50 to 70 percent efficiency in preventing infections based on global studies at the time, other brands such as Pfizer and AstraZeneca from the United States and United Kingdom have over 90 percent efficiency.
The story should be all about the completion of the contract and
how the Western Pharma can't meet its obligation (mind you the contract payment had been paid in advance by loan from World Bank which the bank itself paid directly to Western Pharma) ,that is the main topic and the newspaper should ask that difficult question, instead they need to spin and cover it up by reporting the low efficacy compare with the western brand.